Sequel Med Tech has offered insight into the next steps of the launch of its twiist automated insulin delivery (AID) system. The company shared at last month’s American Diabetes Association’s 85th Scientific Sessions in Chicago that it planned to begin the launch of the highly anticipated twiist system. The initial launch comes with the Abbott […]
Business/Financial News
Insulet hires new chief HR officer from J&J
Insulet (Nasdaq:PODD) announced that it named Lisa Blair Davis as its new SVP and chief human resources officer. She joins the automated insulin delivery technology maker from Johnson & Johnson. There, she most recently served as VP of global human resources for Johnson & Johnson MedTech. SVP and Chief Medical Officer, Dr. Trang Ly, spoke […]
Medtronic Diabetes names CFO with consumer experience ahead of separation
Medtronic (NYSE:MDT) announced today that it appointed Chad Spooner as CFO of MiniMed in advance of its intended separation. Effective July 14, Spooner takes responsibility for overseeing the finance function for Medtronic Diabetes/MiniMed. His role includes supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as the unit prepares to become independent. The […]
Diabeloop launches insulin delivery algorithm in Germany
Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in Germany. The companies distribute their automated insulin delivery offering through Mediq, a leading European diabetes provider. Mediq serves as the exclusive distributor for the DBLG1 system and the Dana-i pump by Sooil. Paris-based Diabeloop develops therapeutic artificial […]
Lifecare takes next steps in CGM implant development
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant. The Norway-based company says it completed the initial electromagnetic compatibility (EMC) testing of electronics developed for its next-generation CGM implant. EMC testing ensures that the implant can operate reliably when surrounded by mobile phones, […]
Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its auto-injector. The Chinese National Medical Products Administration (NMPA) approved Maxdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Innovent Biologics. It treats people with obesity through delivery with an YpsoMate 1.0 auto-injector variant. YpsoMate, a user-friendly […]
Convatec wins FDA approval for Parkinson’s treatment infusion tech
Convatec announced today that it received FDA approval for the delivery of a Parkinson’s disease therapy through its Neria Guard infusion set. The FDA approved apomorphine hydrochloride for subcutaneous infusion for the treatment of Parkinson’s. London-based Convatec’s Neria Guard set delivers the therapy under the skin (subcutaneous) as a continuous infusion via a small portable […]
The biggest diabetes tech stories out of ADA 2025
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association’s 85th Scientific Sessions. At last year’s edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 remained a hot topic, alongside new players in the continuous glucose monitor (CGM) and automated insulin delivery market, […]
Senseonics lays out hopes for next-gen CGM commercial timelines
Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose monitors (CGMs). The maker of the Eversense 365 year-long implantable CGM hosted an analyst event during the American Diabetes Association’s 85th Scientific Sessions in Chicago this past weekend. At that event, the company touched on the commercial strategy for Eversense […]
Mannkind looks to give those with diabetes another option through inhaled insulin
For those living with diabetes, MannKind offers a very different alternative to the current methods of insulin delivery. Founded in 1991 by Alfred E. Mann, a medtech visionary who played a large part in the wider adoption of insulin pumps as the founder of MiniMed, the company develops Afrezza — a fast-acting insulin formulation delivered […]